NK cell activation in the tumor followed the same kinetics as T cell activation, but unlike CD8+ T cells, MEDI9197 did not increase the proportion of NK cells in the tumor (Additional file 1: Figure S6A and B). The gene discussed is CD8A; the disease is neoplasm.